Insmed Inc
F:IM8N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Insmed Inc
F:IM8N
|
US |
|
Nixxy Inc
NASDAQ:NIXX
|
US |
|
K-Bro Linen Inc
TSX:KBL
|
CA |
|
S
|
Southern Copper Corp
LSE:0L8B
|
US |
|
C
|
Caterpillar Inc
XMUN:CAT1
|
US |
|
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
US |
|
Almirall SA
F:E2Z
|
ES |
|
E
|
Emerson Electric Co
F:EMR
|
US |
|
H
|
Han Kook Capital Co Ltd
KOSDAQ:023760
|
KR |
|
Breakthrough Minerals Ltd
ASX:BTM
|
AU |
|
Hang Lung Properties Ltd
HKEX:101
|
HK |
|
SHIFT Inc
OTC:SFTTF
|
JP |
|
Hankyu Hanshin REIT Inc
TSE:8977
|
JP |
|
G
|
Gold Hart Copper Corp
XTSX:HART
|
CA |
|
Coway Co Ltd
KRX:021240
|
KR |
|
B
|
Barco NV
OTC:BCNAY
|
BE |
|
Orezone Gold Corp
F:OEX
|
CA |
Bankruptcy Probability
Insmed Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Insmed Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Insmed Inc
NASDAQ:INSM
|
26.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Insmed Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Insmed Inc has total debt of 722.2m USD. This includes both short-term (0 USD) and long-term (722.2m USD) debt.
You can find a full breakdown on its Balance Sheet.